A

NYSE

AGILENT TECHNOLOGIES, INC.

Health Care, Life Sciences Tools & Services

$145.97

close 7 Aug 2026

+27.90%

52-week change

$41.20B

market cap

$108.35

$160.27

52-week range

Expected price

$138.51 – $169.29

Current price

$145.97

Signal

Appears fairly valued

A historical-multiple reference, never a fair-value claim. The band uses only data public at each date and ends at the latest month — no forward estimates.

Current multiples

P/E (TTM)29.31x

P/S (TTM)5.70x

P/B5.78x

EV/EBITDA (TTM)23.36x

FCF yield (TTM)2.64%

PEG (TTM, GAAP)9.71

Context

P/E, own 5-year average31.50x

P/E, sector median29.65x*

Price at 5-year median P/E$153.00*

Indicated dividend yield0.70%

Forward — analyst consensus

Forward P/E (FY2026)24.09x*

Forward P/E (FY2027)22.08x

Forward PEG2.65*

Consensus EPS FY2026 (21 analysts)$6.06

EPS growth (FY2026→FY2027)9.10%

Revenue growth (FY2026)7.20%

Street view

Price target (mean)$159.32*

Target upside9.14%

Ratings (buy / hold / sell)17 / 4 / 0

FY2026 EPS revisions, 30d (up / down)2 / 2

5-year history

Dashed line: average of month-end values

P/E (TTM)

P/S (TTM)

P/B

FCF yield (TTM)

Dividend yield

period to 30 Apr 2026, filed 1 Jun 2026, close 7 Aug 2026

Discounted cash flow

Ten projected years plus a perpetuity, prefilled from filings — a model to argue with, never a fair-value claim.

Free cash flow, last ten years and TTM

5Y CAGR +7.51%10Y CAGR +10.78%

Assumptions

Growth rate, years 1–10%

Perpetual growth%Discount rate%

Base FCF$M

As filed — not assumptions

Current price$145.97

Cash & equivalents$1.81B

Total debt$3.36B

Shares outstanding282.22M

Result

DCF price per share$100.67

Current price$145.97

Margin of safety-31.03%

PV of years 1–10$10.60B

PV of terminal value$19.36B

Equity value$28.41B

Market-implied growth+12.08%

Projected FCF, years 1–10

Hover for PV and growth

Projection detail

Override growth for any year; blank years use the uniform rate

Year	2026	2027	2028	2029	2030	2031	2032	2033	2034	2035	Terminal
Growth, %											2.5
FCF	$1.17B	$1.26B	$1.35B	$1.45B	$1.56B	$1.68B	$1.80B	$1.94B	$2.09B	$2.24B	$41.79B
PV	$1.08B	$1.08B	$1.07B	$1.07B	$1.06B	$1.06B	$1.05B	$1.05B	$1.04B	$1.04B	$19.36B

period to 30 Apr 2026, filed 1 Jun 2026, close 7 Aug 2026